Earnings · China A-shares
JIANMIN PHARMACEUTICAL GROUP CO LTD. Class A (600976) earnings
JIANMIN PHARMACEUTICAL GROUP CO LTD. Class A published its Q3 report on 2026-10-21: net profit -16.60% year on year, -18.78% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -1.95% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-21
- Period end
- 2026-09-30
- Net profit YoY
- -16.60%
- Excl. one-offs YoY
- -18.78%
- Net profit QoQ
- -31.74%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -4.48% | — |
| 3 days | -1.95% | — |
| 7 days | -2.02% | — |
| 14 days | +2.68% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 2 of 8 reports (average -0.07%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-22 | ¥238.29M | -16.60% | -18.78% | -9.98% | 1.57 | 8.83% | -1.95% | — | — |
| 2026 interim report | 2026-08-20 | ¥177.21M | -19.68% | -21.48% | -10.72% | 1.17 | 6.57% | -2.75% | -4.87% | +0.82% |
| 2026 Q1 report | 2026-04-18 | ¥87.73M | -20.37% | -25.94% | -2.13% | 0.58 | 3.25% | -1.50% | -16.21% | -20.97% |
| 2025 annual report | 2026-03-21 | ¥359.84M | -0.65% | -0.05% | -3.85% | 2.37 | 14.26% | +4.10% | +3.23% | -3.94% |
| 2025 Q3 report | 2025-10-22 | ¥285.74M | -11.16% | -5.58% | -11.43% | 1.88 | 11.42% | -2.99% | -8.59% | -7.26% |
| 2025 interim report | 2025-08-20 | ¥220.63M | -7.83% | +0.61% | -10.20% | 1.46 | 8.83% | -1.99% | -4.18% | -14.23% |
| 2025 Q1 report | 2025-04-19 | ¥110.18M | +10.70% | +13.92% | -8.04% | 0.73 | 4.42% | -2.16% | -11.64% | -14.58% |
| 2024 annual report | 2025-03-22 | ¥362.18M | -30.54% | -30.80% | -16.81% | 2.38 | 15.68% | +8.69% | -0.31% | +2.71% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.